Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Endometrioid × copanlisib × 90 days × Clear all

Sponsor

Conditions

Lymphoma 4 Multiple Myeloma 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Melanoma 1 Malignant Solid Neoplasm 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Hematologic Neoplasms 1 HER2 Positive Breast Cancer 1 Glioma 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Specimen Handling 3 olaparib 2 durvalumab 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 defactinib 1 ceralasertib 1 cediranib 1 capivasertib 1 Restraint, Physical 1 RO5126766 1 Immunoglobulin G 1 Hysterectomy 1 Fluid Therapy 1 Disulfides 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡